Abstract

BackgroundBiliary intraepithelial neoplasia (BilIN) is often distinguished by what it is not: the precancerous lesions are not mass-forming, are not the cause of bile duct obstruction, and are small enough (less than 5 mm long) to evade detection by the naked eye. Here, we describe an atypical case of BilIN resembling cholangiocarcinoma (CC) that was large enough to be identified by diagnostic imaging and presented with obstructive jaundice caused by a hematoma in the common bile duct (CBD).Case presentationA 64-year-old man presented to our hospital with upper abdominal pain and anorexia. Initial laboratory examinations revealed increased total bilirubin and a computed tomography (CT) scan revealed a dilated CBD. Gastroenterologists performed an endoscopic sphincterotomy (EST), which revealed that the cause of obstructive jaundice was a hematoma in the CBD. Enhanced CT scan and magnetic resonance cholangiopancreatography (MRCP) performed after the hematoma was drained showed improved dilation of the CBD and an enhanced wall thickness of bile duct measuring 25 × 10 mm at the union of the cystic and common hepatic ducts. A cholangioscope detected an elevated tumor covered by sludge in the CBD, and we performed an extrahepatic bile duct resection and cholecystectomy. The postoperative course was uneventful and the pathological examination of the resected tumor revealed that although the ulcerated lesion had inflammatory granulation tissue, it did not contain the components of invasive carcinoma. Many consecutive intraepithelial micropapillary lesions spread around the ulcerated lesion, and the epithelial cells showed an increased nucleus-to-cytoplasm ratio, nuclear hyperchromasia, and architectural atypia. The pathological diagnosis was BilIN-1 to -2. Immunohistochemical staining showed that S100P was slightly expressed and MUC5AC was positive, while MUC1 was negative and p53 was not overexpressed.ConclusionWe experienced an atypical case of BilIN mimicking CC that presented with obstructive jaundice caused by a hematoma in the CBD. Our case suggested that the occurrence of BilIN can be triggered by factors other than inflammation, and can grow to a size large enough to be detected by image analyses.

Highlights

  • ConclusionWe experienced an atypical case of BilIN mimicking CC that presented with obstructive jaundice caused by a hematoma in the common bile duct (CBD). Our case suggested that the occurrence of BilIN can be triggered by factors other than inflammation, and can grow to a size large enough to be detected by image analyses. Keywords: Biliary intraepithelial neoplasia (BilIN), Cholangiocarcinoma, Bile duct

  • Biliary intraepithelial neoplasia (BilIN) is often distinguished by what it is not: the precancerous lesions are not mass-forming, are not the cause of bile duct obstruction, and are small enough to evade detection by the naked eye

  • We experienced an atypical case of BilIN mimicking CC that presented with obstructive jaundice caused by a hematoma in the common bile duct (CBD)

Read more

Summary

Conclusion

We experienced an atypical case of BilIN mimicking CC that presented with obstructive jaundice caused by a hematoma in the CBD. Our case suggested that the occurrence of BilIN can be triggered by factors other than an inflammatory condition and can potentially grow to a size large enough to be detected by diagnostic imaging. Abbreviations Anti-HCV: Antibodies to hepatitis C virus; BilIN: Biliary intraepithelial neoplasia; CA19–9: Cancer antigen 19–9; CBD: Common bile duct; CC: Cholangiocarcinoma; CEA: Carcinoembryonic antigen; CRP: C-reaction protein; CT: Computed tomography; ERCP: Endoscopic retrograde cholangiopancreatography; EST: Endoscopic sphincterotomy; HBsAg: Hepatitis B surface antigen; IPNB: Intraductal papillary neoplasm of bile duct; MCN: Mucinous cystic neoplasm; MRCP: Magnetic resonance cholangiopancreatography; PanIN: Pancreatic intraepithelial neoplasia; PSC: Primary sclerosing cholangitis; WBC: White blood cell

Background
Findings
Discussion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.